Q3 Earnings Forecast for SBC Medical Group Issued By Sidoti

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Stock analysts at Sidoti upped their Q3 2026 EPS estimates for shares of SBC Medical Group in a research note issued on Monday, August 17th. Sidoti analyst A. Shah now expects that the company will earn $0.12 per share for the quarter, up from their previous forecast of $0.11. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.47 per share. Sidoti also issued estimates for SBC Medical Group’s Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.47 EPS, Q1 2027 earnings at $0.12 EPS, Q2 2027 earnings at $0.13 EPS, Q3 2027 earnings at $0.14 EPS and FY2027 earnings at $0.52 EPS.

SBC Medical Group (NASDAQ:SBC) last announced its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%.The company had revenue of $49.19 million during the quarter, compared to the consensus estimate of $45.37 million.

A number of other equities research analysts also recently weighed in on SBC. Wall Street Zen upgraded SBC Medical Group from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings lowered SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 22nd. Finally, BTIG Research reissued a “buy” rating and set a $8.00 price objective on shares of SBC Medical Group in a report on Thursday, August 13th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $8.50.

SBC Medical Group Stock Performance

SBC stock opened at $3.65 on Tuesday. The company has a 50 day moving average price of $3.10 and a 200 day moving average price of $3.55. SBC Medical Group has a fifty-two week low of $2.78 and a fifty-two week high of $5.07. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The stock has a market capitalization of $374.42 million, a PE ratio of 7.77 and a beta of 0.59.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of SBC. Geode Capital Management LLC bought a new stake in SBC Medical Group in the 2nd quarter valued at about $455,000. XTX Topco Ltd bought a new position in shares of SBC Medical Group in the second quarter worth $64,000. New York State Common Retirement Fund bought a new position in shares of SBC Medical Group in the second quarter worth $104,000. Millennium Management LLC acquired a new position in SBC Medical Group in the third quarter valued at about $219,000. Finally, Williams & Novak LLC acquired a new position in SBC Medical Group in the fourth quarter valued at about $65,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.